Abstract

There is an increased recognition in the field of toxicology of the value of medium-to-high-throughput screening methods using in vitro and alternative animal models. We have previously introduced the asexual freshwater planarian Dugesia japonica as a new alternative animal model and proposed that it is particularly well-suited for the study of developmental neurotoxicology. In this article, we discuss how we have expanded and automated our screening methodology to allow for fast screening of multiple behavioral endpoints, developmental toxicity, and mortality. Using an 87-compound library provided by the National Toxicology Program, consisting of known and suspected neurotoxicants, including drugs, flame retardants, industrial chemicals, polycyclic aromatic hydrocarbons (PAHs), pesticides, and presumptive negative controls, we further evaluate the benefits and limitations of the system for medium-throughput screening, focusing on the technical aspects of the system. We show that, in the context of this library, planarians are the most sensitive to pesticides with 16/16 compounds causing toxicity and the least sensitive to PAHs, with only 5/17 causing toxicity. Furthermore, while none of the presumptive negative controls were bioactive in adult planarians, 2/5, acetaminophen and acetylsalicylic acid, were bioactive in regenerating worms. Notably, these compounds were previously reported as developmentally toxic in mammalian studies. Through parallel screening of adults and developing animals, planarians are thus a useful model to detect such developmental-specific effects, which was observed for 13 chemicals in this library. We use the data and experience gained from this screen to propose guidelines for best practices when using planarians for toxicology screens.

Highlights

  • It has been nearly a decade since the launch of the “Toxicology Testing in the 21st century” (Tox21; www.tox21.gov) federal initiative to transform toxicology testing in the United States

  • We evaluate the capabilities and limitations of this improved planarian medium-throughput screening (MTS) platform by testing a library of 87 compounds provided by the National Toxicology Program (NTP), consisting of known and suspected developmental neurotoxicants and negative controls

  • Regardless of provided concentration, were treated the same. 0.5% dimethyl sulfoxide (DMSO) was used as solvent control, because we have previously shown that there are no effects on planarian morphology or behavior at this concentration (Hagstrom et al, 2015)

Read more

Summary

Introduction

It has been nearly a decade since the launch of the “Toxicology Testing in the 21st century” (Tox; www.tox21.gov) federal initiative to transform toxicology testing in the United States. Connecting those HTS data to their in vivo relevancy to be predictive of effects on human health remains challenging as important aspects of biology, such as xenobiotic metabolism and interactions between cell types, are inherently missing in these in vitro systems These assays often focus on key molecular and cellular targets underlying known toxicity pathways, more knowledge is needed to connect these molecular and cellular effects to functional consequences on organismal health to discern their significance. Realizing this need and the urgency of the matter, the development of medium-throughput screening (MTS)-amenable alternative animal models, such as zebrafish and nematodes, was encouraged as part of the Tox initiative. Despite these advantages, the toxicology community remains divided on the added value of these alternative systems, as each has its own drawbacks, species-specific sensitivities and discrepancies with humans, as with any system (Boyd et al, 2015; Scholz, 2013)

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.